KraneShares MSCI All China Health Care Index ETF (KURE)

NYSEARCA: KURE · IEX Real-Time Price · USD
+0.11 (0.82%)
At close: Jun 24, 2024, 2:51 PM
+0.04 (0.27%)
After-hours: Jun 24, 2024, 6:30 PM EDT
Assets $40.47M
Expense Ratio 0.65%
PE Ratio 15.75
Shares Out 2.90M
Dividend (ttm) $0.11
Dividend Yield 0.83%
Ex-Dividend Date Dec 18, 2023
Payout Ratio 12.98%
1-Year Return -23.92%
Volume 4,547
Open 13.50
Previous Close 13.47
Day's Range 13.50 - 13.69
52-Week Low 13.47
52-Week High 19.48
Beta 0.70
Holdings 64
Inception Date Feb 1, 2018

About KURE

Fund Home Page

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is issued by KraneShares.

Asset Class Equity
Category China Region
Region Asia-Pacific
Stock Exchange NYSEARCA
Ticker Symbol KURE
ETF Provider KraneShares
Index Tracked MSCI China All Shares Health Care 10/40 Index

Top 10 Holdings

45.22% of assets
Name Symbol Weight
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760.SZ 9.68%
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276.SS 6.96%
BeiGene Ltd Ordinary Shares BEIGF 5.20%
CSPC Pharmaceutical Group Ltd 1093.HK 4.52%
WuXi Biologics (Cayman) Inc 2269.HK 3.70%
Innovent Biologics Inc 1801.HK 3.66%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A 600436.SS 3.46%
Wuxi AppTec Co Ltd Class A 603259.SS 2.79%
Aier Eye Hospital Group Co Ltd Class A 300015.SZ 2.68%
Shanghai United Imaging Healthcare Co Ltd Class A 688271.SS 2.57%
View More Holdings


Ex-Dividend Amount Pay Date
Dec 18, 2023 $0.11284 Dec 20, 2023
Dec 28, 2022 $0.0104 Dec 30, 2022
Dec 29, 2021 $4.05354 Dec 31, 2021
Dec 29, 2020 $0.00011 Dec 31, 2020
Dec 27, 2019 $0.0573 Dec 31, 2019
Dec 26, 2018 $0.03661 Dec 28, 2018
Full Dividend History


KraneShares Debuts Umbrella China ETF

The newest ETF is a fund-of-funds composed of existing China ETFs.

2 years ago - ETFcom

Best Pharmaceutical ETFs for Q2 2021

The best pharmaceutical ETFs for Q2 2021 are KURE, MJJ, and POTX.

3 years ago - Investopedia

China Continues to Be Risky for Investors. What to Expect in 2021.

China risks are on multiple fronts—from the technology rivalry with the U.S. to more regulatory scrutiny inside China of internet giants.

Other symbols: CHIQCXSEKWEB
3 years ago - Barrons

Best Healthcare ETFs for Q1 2021

The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.

Other symbols: ARKGPTH
3 years ago - Investopedia

The Tell: China's bouncing back, but don't bet on other emerging markets to join the ride

China's economy is bouncing back, but other emerging markets aren't likely to enjoy the spoils, says one economist.

3 years ago - Market Watch

Chinese stocks have biggest gains in 3 months

Yahoo Finance's Tom Belger reports on the latest stock news from China and Europe.

Other symbols: CNXTKWEB
4 years ago - Yahoo Finance

COVID Impact Varies Across Emerging Market ETFs

Emerging markets have been hit hard by coronavirus, but some were hit harder than others.

4 years ago - ETFcom

A New Emerging Markets ETF With A Surprise Exclusion

It's not unusual for an emerging markets exchange traded fund to use exclusionary tactics. What is unusual is when an emerging market ETF offering access to multiple developing economies excludes Chin...

Other symbols: KGRN
5 years ago - Benzinga